Donald L Budenz MD MPH

Cataract Related, Glaucoma Related

Professor and Medical Director

Summary

Dr. Donald Budenz is an ophthalmologist based in Miami, FL, with subspecialties in cataract and glaucoma. He completed his fellowship in glaucoma at the Bascom Palmer Eye Institute/University of Miami Hospital and Clinics and holds a medical degree from Harvard. His professional tenure includes roles as a Professor of Ophthalmology and Epidemiology at the University of Miami/Bascom Palmer Eye Institute and Chairman of Ophthalmology at UNC Chapel Hill School of Medicine. Dr. Budenz has significant experience in glaucoma diagnosis and management, gonioscopy, ocular hypertension, trabeculectomy, glaucoma tube implant surgery, and cataracts. He has contributed to multiple publications, including research on glaucoma epidemiology, genetics, glaucoma diagnostics, and is involved in clinical trials focused on glaucoma. His accolades include serving as President of the Association of University Professors of Ophthalmology and American Glaucoma Society and receiving a Life Achievement Award from the American Academy of Ophthalmology.

Cataracts, Glaucoma, Public speaking, Clinical research, Gonioscopy, Trabeculectomy, Visual field testing, Ocular hypertension, Vision disorders, Ophthalmic Imaging, Cataract And Anterior Segment

Johns Hopkins Bloomberg School of Public HealthMPH, Epidemiology and International Health, 2002 - 2004
University of Miami Hospital and ClinicsFellowship, Glaucoma, 1991 - 1992
University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 1988 - 1991
Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 1987 - 1988
Harvard Medical SchoolClass of 1987

PubMed

Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®.
Steven J Gedde, Natasha Nayak Kolomeyer, Pratap Challa, Vikas Chopra, Kateki Vinod
Ophthalmology. 2026-04-01
Primary Angle-Closure Disease Preferred Practice Pattern®.
Steven J Gedde, Vikas Chopra, Kateki Vinod, Eileen C Bowden, Natasha Nayak Kolomeyer
Ophthalmology. 2026-04-01
Primary Open-Angle Glaucoma Preferred Practice Pattern®.
Steven J Gedde, Eileen C Bowden, Pratap Challa, Kateki Vinod, Natasha Nayak Kolomeyer
Ophthalmology. 2026-04-01

Journal Articles

Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up
Budenz DL, Feuer WJ, Barton K, Schiffman J, Costa VP, Godfrey DG, Buys YM; Ahmed Baerveldt Comparison Study Group, American Journal of Ophthalmology, 1/1/2016
Effect of adjusting retinal nerve fiber layer profile to fovea-disc angle axis on the thickness and glaucoma diagnostic performance
Mwanza, JC, Lee, G, Budenz, DL, American Journal of Ophthalmology, 1/1/2016
Optical coherence tomography platforms and parameters for glaucoma diagnosis and progression
Mwanza JC, Budenz DL, Current Opinion in Ophthalmology, 1/1/2016

Books/Book Chapters

Curbside Consultations in Glaucoma
Chapter: Which Aqueous Shunt Should I Use?
Page 207 - 210Budenz, DLEditors: Gedde SJ, Panarelli, JF, Heuer DK, Lewis RA.SLACK, Inc, Thorofare, NJEdition 2nd,2015
Glaucoma
Chapter: Practical Applications of Glaucoma Care in Different Societies
Page 30 - 39Robin, A, Budenz, DL, Congdon, NG, Thulasiraj, RDEditors: Shaarawy, TM, Sherwood, MB, Hitchings, RA, Crowston, JG.Elsevier Saunders, London, UKEdition 2nd,2015
Ophthalmology
Chapter: Visual Field Testing in Glaucoma
Page 1029 - 1035Budenz, DLEditors: Yanoff, M and Duker, JS.Saunders Elsevier, Philadelphia, PAEdition 4th,2014

Lectures

Ophthalmic Imaging 2016: Optical Coherent Tomography (OCT) Applications and Future Technology
Palm Beach, FL - 1/5/2015
Glaucoma 2014: Battle on the Beach Revisited
Miami, FL - 1/25/2014
The Essential of Ocular Imaging Course version 3.0
Durham, NC - 1/24/2014

Other

Subspecialty fellowships. In: Program Directors Guide
Gedde SJ, Budenz DL, http://aaophp.aao.org/pdg
1/1/2006

Nicox Appoints Robert N. Weinreb, M.D. And Sanjay G. Asrani, M.D. To Its Glaucoma Clinical Advisory BoardJuly 12th, 2021
Top Line Results from Glaucoma Dolomites Phase 2 Trial Show Nicox's NCX 470 Meets Primary Endpoint and Demonstrates Statistical Superiority vs LatanoprostOctober 1st, 2019
Nicox Establishes High-Profile Glaucoma Clinical Advisory BoardMay 6th, 2019